In the context of the built environment, the most basic goal of Platform construction (P-DfMA) is to drive value within the sector - to apply the lessons of manufacturing to construction, and do what we do better, more efficiently and more productively.
They are the embodiment of a system.The core purpose of the project drives the analysis that informs the selection of Chips..
Defining Chips for the project.At a point in each project, we go through the process of defining Chips for that project, in order to develop a Chip library.This can start with a reference design, or a blank piece of paper.
Or we might start with a similar type of project for which we've generated Chips in the past.. Chips can be made at different levels.A chip is not a module or a piece of equipment, it's a part of a chain.
Depending on the problem you're trying to address, you can set the level of the size of the Chip to the level that is appropriate to your analysis.
A chip can, therefore, be a whole factory, a building, a production line, or a single machine within a production line.And how could we do better in our approach to pharmaceutical facility design?.
We developed a particular set of tools and an approach that over time became what we now refer to as Design to Value.As we have evolved this approach over the years, we’ve extended it to include many more pharmaceutical engineering projects, as well as a wide range of other sectors, from heavy industry to prisons.. Part of our role is to act as pharmaceutical plant design consultants.
What we aim to do is make sure that projects are well aligned with business requirements; to define and design future assets that translate a company’s strategic objectives into tangible manufacturing facilities – and provide added value.The key point here is that we put a great deal of effort into defining the business needs.
(Editor: New Diffusers)